Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna)

James W. Carpenter Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506.

Search for other papers by James W. Carpenter in
Current site
Google Scholar
PubMed
Close
 MS, DVM
,
Robert P. Hunter Zoological Pharmacology Laboratory, Department of Anatomy & Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506.

Search for other papers by Robert P. Hunter in
Current site
Google Scholar
PubMed
Close
 PhD
,
John H. Olsen Busch Gardens Tampa Bay, Tampa, FL 33674.

Search for other papers by John H. Olsen in
Current site
Google Scholar
PubMed
Close
 DVM
,
Heather Henry Busch Gardens Tampa Bay, Tampa, FL 33674.

Search for other papers by Heather Henry in
Current site
Google Scholar
PubMed
Close
,
Ramiro Isaza Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506.

Search for other papers by Ramiro Isaza in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
David E. Koch Zoological Pharmacology Laboratory, Department of Anatomy & Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506.

Search for other papers by David E. Koch in
Current site
Google Scholar
PubMed
Close
 MS

Abstract

Objective—To determine the pharmacokinetics of marbofloxacin after single IV and orally administered doses in blue and gold macaws.

Animals—10 healthy blue and gold macaws.

Procedures—In a crossover study, marbofloxacin (2.5 mg/kg) was administered orally (via crop gavage) to 5 birds and IV to 5 birds. Blood samples were obtained at 0, 0.5, 1, 3, 6, 12, 24, 48, 72, and 96 hours after marbofloxacin administration. After a 4-week washout period, the study was repeated, with the first 5 birds receiving the dose IV and the second 5 birds receiving the dose orally. Serum marbofloxacin concentrations were quantitated by use of a validated liquid chromatography–mass spectrometry assay.

Results—After oral administration, mean ± SD area under the curve was 7.94 ± 2.08 μg•h/mL, maximum plasma concentration was 1.08 ± 0.316 μg/mL, and bioavailability was 90.0 ± 31%. After IV administration of marbofloxacin, the apparent volume of distribution was 1.3 ± 0.32 L/kg, plasma clearance was 0.29 ± 0.078 L/h/kg, area under the curve was 9.41 ± 2.84 μg•h/mL, and the harmonic mean terminal half-life was 4.3 hours.

Conclusions and Clinical Relevance—Single IV and orally administered doses of marbofloxacin were well tolerated by blue and gold macaws. The orally administered dose was well absorbed. Administration of marbofloxacin at a dosage of 2.5 mg/kg, PO, every 24 hours may be appropriate to control bacterial infections susceptible to marbofloxacin in this species.

Abstract

Objective—To determine the pharmacokinetics of marbofloxacin after single IV and orally administered doses in blue and gold macaws.

Animals—10 healthy blue and gold macaws.

Procedures—In a crossover study, marbofloxacin (2.5 mg/kg) was administered orally (via crop gavage) to 5 birds and IV to 5 birds. Blood samples were obtained at 0, 0.5, 1, 3, 6, 12, 24, 48, 72, and 96 hours after marbofloxacin administration. After a 4-week washout period, the study was repeated, with the first 5 birds receiving the dose IV and the second 5 birds receiving the dose orally. Serum marbofloxacin concentrations were quantitated by use of a validated liquid chromatography–mass spectrometry assay.

Results—After oral administration, mean ± SD area under the curve was 7.94 ± 2.08 μg•h/mL, maximum plasma concentration was 1.08 ± 0.316 μg/mL, and bioavailability was 90.0 ± 31%. After IV administration of marbofloxacin, the apparent volume of distribution was 1.3 ± 0.32 L/kg, plasma clearance was 0.29 ± 0.078 L/h/kg, area under the curve was 9.41 ± 2.84 μg•h/mL, and the harmonic mean terminal half-life was 4.3 hours.

Conclusions and Clinical Relevance—Single IV and orally administered doses of marbofloxacin were well tolerated by blue and gold macaws. The orally administered dose was well absorbed. Administration of marbofloxacin at a dosage of 2.5 mg/kg, PO, every 24 hours may be appropriate to control bacterial infections susceptible to marbofloxacin in this species.

All Time Past Year Past 30 Days
Abstract Views 52 0 0
Full Text Views 9262 8995 125
PDF Downloads 246 122 27
Advertisement